Veran Medical Technologies, Inc.

BTG International invests in the life sciences, physical sciences, ageing & neuroscience, multimedia/networking, biopharmaceuticals, nanotechnology, medical devices/diagnostics, optoelectronics, oncology, polymer electronics and semiconductors sectors. The firm seeks early-stage companies with dedicated people, novel technologies, and significant market opportunities. While they focus on seed and early-stage investments, they may consider attractive later-stage investments.

River Cities Capital Funds focuses on investments in high-growth information technology and healthcare companies in the following industries: software-as-a-service (SaaS), enterprise or infrastructure software, business process outsourcing and devices. The firm invests mainly in expansion-stage companies with revenues of $3 million to $15 million. They may also occasionally make seed stage investments in companies with less than $1 million in trailing 12-month revenue, early-stage investments in companies with $1 million to $3 million in trailing 12-month revenue and late-stage investments in companies with greater than $15 million in trailing 12-month revenue. River Cities targets companies in the Midwestern and Southeastern US.

Rex Health Ventures (RHV) supports the discovery and development of new treatments, tools, products and services that foster innovation and positively impact the provision of healthcare. The seek to help companies and entrepreneurs bring their products and services into the healthcare market. The firm makes seed and early-stage investments. RHV will consider pre-revenue opportunities, but they generally prefer companies that have at least developed a prototype or beta product. The firm is particularly interested in investments in the following sectors: healthcare information technology, healthcare services, medical devices and BioPharma technologies. Initial investments range from $250,000 to $500,000 and total per company investments range from $500,000 to $2 million. RHV targets investments where there is a realistic possibility of exit within 5 to 7 years.